Grupo Oftalmo-Biología Experimental
![Foto de Grupo Oftalmo-Biología Experimental](/img/grupo.png)
![Foto de Universidad de Navarra](/img/noimage_org.png)
Universidad de Navarra
Pamplona, EspañaPublicaciones en colaboración con investigadoras/es de Universidad de Navarra (11)
2023
-
Recovery course of persistent posterior subretinal fluid after successful repair of rhegmatogenous retinal detachment
European Journal of Ophthalmology
2022
-
The role of retinal fluid location in atrophy and fibrosis evolution of patients with neovascular age-related macular degeneration long-term treated in real world
Acta ophthalmologica, Vol. 100, Núm. 2, pp. e521-e531
2020
-
Bimonthly, treat-and-extend and as-needed ranibizumab in naïve neovascular age-related macular degeneration patients: 12-month outcomes of a randomized study
Acta Ophthalmologica, Vol. 98, Núm. 7, pp. e820-e829
-
Genetic and environmental factors related to the development of myopic maculopathy in Spanish patients
PloS one, Vol. 15, Núm. 7, pp. e0236071
2017
-
Development of an activity disease score in patients with uveitis (UVEDAI)
Rheumatology International, Vol. 37, Núm. 4, pp. 647-656
2016
2015
-
Individualized Therapy with Ranibizumab in Wet Age-Related Macular Degeneration
Journal of Ophthalmology, Vol. 2015
-
Intravitreal anti-vascular endothelial growth factor therapy for choroidal neovascularization secondary to pathologic myopia six years outcome
Retina, Vol. 35, Núm. 12, pp. 2450-2456
2014
-
A Delphi study to detect deficiencies and propose actions in real life treatment of neovascular age-related macular degeneration
Journal of Ophthalmology, Vol. 2014
-
Do nutritional supplements have a role in age macular degeneration prevention?
Journal of Ophthalmology, Vol. 2014
1997
-
Predictors of tobacco addiction in young adults
Revista de medicina de la Universidad de Navarra, Vol. 41, Núm. 3, pp. 167-172